Press "Enter" to skip to content

India tops the chart for approved biosimilars and clinical trials surpassing USA and Europe: 10th Annual Pharma IPR India Conference

The event witnessed innovative exchange of thoughts with an aim to create an efficient IP framework globally to bolster the potential of growth, investments, and collaboration amid crises.

Original source: https://health.economictimes.indiatimes.com/news/pharma/86482496?utm_source=RSS&utm_medium=ETRSS